• Nie Znaleziono Wyników

The giant aortic root aneurysm related to bicuspid aortic valve treated with valve-sparing operation

N/A
N/A
Protected

Academic year: 2022

Share "The giant aortic root aneurysm related to bicuspid aortic valve treated with valve-sparing operation"

Copied!
2
0
0

Pełen tekst

(1)

Address for correspondence: Radosław Gocoł, MD, Department of Cardiac Surgery, Upper Silesian Heart Center, ul. Ziołowa 45/47, 40–635 Katowice, Poland, tel: +48 605401558, e-mail: gocot@poczta.onet.pl

Received: 22.03.2019 Accepted: 26.05.2019

The giant aortic root aneurysm related to bicuspid aortic valve treated

with valve-sparing operation

Radosław Gocoł

1

, Aleksandra Żak

1

, Joanna Ciosek

2

, Marek A. Deja

1, 3

1Department of Cardiac Surgery, Upper-Silesian Heart Center, Katowice, Poland

23rd Division of Cardiology and Structural Heart Diseases, Upper-Silesian Heart Center, Katowice, Poland

3Department of Cardiac Surgery, Medical University of Silesia, School of Medicine, Katowice, Poland

A 30-year-old patient was admitted with dysp- nea and severe chest pain radiating to the left scapula. Transesophageal echocardiography (TEE) showed bicuspid aortic valve (BAV) with severe eccentric regurgitation jet along anterior mitral leaflet (Fig. 1A), aneurysm of the root and as- cending aorta with maximum diameter of 130 mm without dissection (Fig. 1B). The aortic ring was 34 mm, left ventricular ejection fraction (EF) 50%

and end-diastolic volume (EDV) 280 mL. Angio- computed tomography showed an enormous an- eurysm (130 × 110 mm, Fig. 1C) involving aortic root and the ascending aorta with normal 34 mm aortic arch. Urgent aortic valve sparing opera- tion modo David was performed. TTE on post-op

7 showed no aortic regurgitation, aortic root of 36 mm (Fig. 1D, E, F), EF 30% and EDV 206 mL.

Subsequently the patient was discharged home. Six months later TTE showed no aortic regurgitation, improvement of EF to 60%, and EDV reduction to 180 mL. Despite the large dilatation of the aortic root and aortic ring, the valve leaflets retained their original structure, which allowed for aortic valve sparing. The key element of the operation was to select the right size of the aortic prosthe- sis, in order to restore physiological relationship between the aortic orifice and aortic cusps. This case demonstrated that the size of aortic root alone cannot constitute a contraindication to the valve sparing procedure.

Conflict of interest: None declared CLINICAL CARDIOLOGY

Cardiology Journal 2019, Vol. 26, No. 4, 420–421

DOI: 10.5603/CJ.2019.0081 Copyright © 2019 Via Medica

ISSN 1897–5593

420 www.cardiologyjournal.org

IMAGE IN CARDIOVASCULAR MEDICINE

(2)

Figure 1. Preoperative transesophageal echocardiography (TEE) showing 130 mm aortic root and ascending aorta aneurysm (A) and severe aortic regurgitation (B); C. Preoperative angio-computed tomography (angio-CT): 130 mm aortic root and ascending aorta aneurysm. Postoperative TEE showing the root and ascending aorta (D) and trace aortic regurgitation (E); F. Postoperative angio-CT showing the aortic root.

www.cardiologyjournal.org 421

Radosław Gocoł et al., The giant aortic root aneurysm

Cytaty

Powiązane dokumenty

C – a transesophageal echocardiographic 4‑chamber view demonstrating severe aortic regurgitation; D – computed tomography of coronary vessels and the dilated ascending

10 Mortality, freedom from reoperation, and freedom from aortic valve regurgitation were analyzed in the entire cohort of patients and in 2 subgroups: patients undergoing VSARR with

tic stenosis (mean gradient, 80 mm Hg; aortic valve area, 0.7 cm 2 ) and left ventricular ejec‑A. tion fraction

ence of >48° angle between the aortic annulus Transcatheter aortic valve implantation (TAVI)4. is a well ‑established modern treatment of severe symptomatic

dergoing aortic valve repair (BAV > TAV) suggests that many patients with AI are still considered for aortic valve repair, except for young patients with a congenital BAV.

1 2 nd Department of Medicine, Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic..

CarnaLife Holo ® (MedApp S.A., Krakow, Poland) visualises the individual patient’s heart as an interactive holographic image based on computed tomography (CT) or a

1) Sustained hemodynamic changes are observed as peak velocity and transvalvular gradient dif- ferences between discharge and follow-up within 1 year after the procedure; 2) BAV